Jasleen Kaur, MD

Letter to the Editor

Zeroing in on Xylazine

August 15, 2024

The authors discuss the need to raise awareness among US public and health care professionals about xylazine due to its infiltration into the illicit drug supply.

Letter to the Editor

Do Not Overlook Bupropion Misuse

April 30, 2024

Jasleen Kaur, MD, and colleagues comment on a case report published in the PCC.

Case Report

Doxepin-Associated Hypoglycemia in a Nondiabetic Patient

July 6, 2023

It is important for clinicians to be aware of the potential impact of antidepressants on glucose regulation.